Treatment with retinoid X receptorgamma-selective ligand (bexarotene) may cause iatrogenic central hypothyroidism.
Asteria
C
C
Institute of Endocrine Sciences, Ospedale Maggiore IRCCS, University of Milan, Italy.
D000818:Animals; D000077610:Bexarotene; D006801:Humans; D007037:Hypothyroidism / Q000139:chemically induced*; D007049:Iatrogenic Disease; D016399:Lymphoma, T-Cell / Q000188:drug therapy; D012176:Retinoids / Q000009:adverse effects* / Q000627:therapeutic use; D012878:Skin Neoplasms / Q000188:drug therapy; D013764:Tetrahydronaphthalenes
D012176:Retinoids; D013764:Tetrahydronaphthalenes; D000077610:Bexarotene